Who Should Not Use Mounjaro?

Mounjaro is an effective weight-loss medication for many people — but it is not suitable for everyone.

One of the most important parts of safe prescribing is knowing who should not use Mounjaro, or who may need additional assessment before treatment is considered. Unfortunately, this aspect is often under-explained online, leaving patients uncertain about their eligibility and safety.

This guide sets out a clear, pharmacist-led safety checklist, explaining who should not use Mounjaro, who may need extra caution, and why professional assessment matters — based on UK prescribing standards and real-world clinical experience at West Hill Pharmacy, under the clinical leadership of Jaya Authunuri.

Why Suitability Matters More Than Effectiveness

Many weight-loss articles focus on results. In pharmacist-led care, suitability always comes first.

A medication can be effective in theory but inappropriate in practice if:

• medical history is not fully considered
• interactions are overlooked
• physiological risks are underestimated

UK prescribing regulations require that suitability is assessed before treatment is supplied — not after side effects appear.

This checklist approach reflects how safe decisions are made in real clinical settings.

What Mounjaro Is — and Why That Matters for Safety

Mounjaro contains tirzepatide, a prescription-only medicine that affects appetite regulation, digestion, and metabolic signalling.

Because it alters hormonal pathways and slows gastric emptying, it can:

• interact with existing medical conditions
• affect absorption of other medicines
• place additional demands on certain body systems

This is why Mounjaro is only supplied following clinical assessment by a qualified prescriber.

Absolute Reasons Not to Use Mounjaro

There are situations where Mounjaro should not be used at all.

These include:

• pregnancy
• breastfeeding
• known hypersensitivity to tirzepatide or its components

Pregnancy and Planned Pregnancy

Mounjaro is not suitable during pregnancy.

Weight-loss injections are not intended for use whilst pregnant, and weight management during pregnancy follows very different clinical principles.

Patients who:

• are pregnant
• are actively trying to conceive
• may become pregnant

must not use Mounjaro without professional guidance.

This is one of the most important exclusion criteria in prescribing practice.

Breastfeeding Considerations

Breastfeeding is another situation where Mounjaro is not recommended.

There is limited safety data on use during breastfeeding, and the potential risks outweigh any potential benefits.

Patients who are breastfeeding should always discuss alternative approaches with a healthcare professional.

Conditions That Require Extra Caution

Some patients may still be considered for treatment but require additional assessment and monitoring.

These include individuals with:

• significant gastrointestinal conditions
• a history of pancreatitis
• gallbladder disease
• severe reflux or delayed gastric emptying

In pharmacist-led care, these cases are not automatically excluded — but they are reviewed carefully.

What Jaya Authunuri Reviews Before Prescribing

As an Independent Prescribing Pharmacist, Jaya Authunuri assesses:

• full medical history
• current medications
• previous responses to weight-loss treatment
• risk factors for side effects

In his experience, most safety issues are identified before treatment starts, allowing appropriate alternatives or additional safeguards to be put in place.

Mental Health and Eating Disorders

Weight-loss injections may not be appropriate for individuals with:

• active eating disorders
• severe disordered eating patterns
• untreated mental health conditions affecting eating behaviour

These situations require careful consideration and, in some cases, specialist input.

Pharmacist-led assessment helps ensure treatment supports health rather than exacerbating risk.

Other Medical Conditions

Patients often ask whether existing conditions automatically exclude them.

The answer is rarely black-and-white.

Conditions that typically require review include:

• diabetes
• thyroid conditions
• gastrointestinal disorders
• cardiovascular conditions

Assessment focuses on risk, benefit, and monitoring, rather than blanket exclusion.

Medication Interactions and Absorption

Because Mounjaro slows digestion, it can affect how some medicines are absorbed.

This is particularly relevant for:

• oral medications with narrow therapeutic windows
• medicines that require precise timing

Pharmacist-led review ensures interactions are considered before treatment begins.

Contraception and Reproductive Health

For patients of childbearing potential, contraception is a key part of suitability assessment.

Weight-loss injections may affect absorption of oral contraceptives, particularly during dose escalation.

This does not mean treatment is unsuitable — but it does mean contraception advice matters.

Why Online Checklists Are Not Enough

Many online “eligibility quizzes” oversimplify suitability.

In real practice, decisions are based on:

• nuance
• professional judgement
• patient-specific risk factors

This is why UK regulations require prescriber involvement rather than self-selection.

What Happens If You’re Not Suitable?

Not being suitable for Mounjaro does not mean there are no options.

Pharmacist-led care allows:

• alternative approaches to be discussed
• risks to be explained clearly
• decisions to be revisited if circumstances change

Safety always comes first.